The Efficacy and Safety of Fluzopril Combined With Apatinib in Maintenance Treatment of Platinum Resistant Recurrent Ovarian Cancer Patients
Clinical trial NCT06102707 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06102707
- Sponsor
- Qilu Hospital of Shandong University
- Status
- NOT_YET_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-01
- Primary completion
- 2025-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.